PCYN
Procyon Corporation
Price Chart
Latest Quote
$0.20
| Previous Close | $0.20 |
| Open | $0.20 |
| Day High | $0.20 |
| Day Low | $0.20 |
| Volume | 10,000 |
Stock Information
| Shares Outstanding | 8.14M |
| Total Debt | $427K |
| Cash Equivalents | $909K |
| Revenue | $4.98M |
| Net Income | $-313K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.64M |
| EPS (TTM) | $-0.04 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.26M |
| Sales | $4.98M |
| Income | $-313K |
| Book/sh | $0.27 |
| Cash/sh | $0.11 |
| Employees | 19 |
Financial Ratios
| Quick Ratio | 1.85 |
| Current Ratio | 3.08 |
| Debt/Eq | 18.66 |
| EPS Growth TTM | 407.00% |
Returns & Margins
| ROA | -4.28% |
| ROE | -13.91% |
| Gross Margin | 78.07% |
| Operating Margin | 0.63% |
| Profit Margin | -6.84% |
Ownership
| Insider Ownership | 64.47% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 1.59 |
| P/S | 0.33 |
| P/B | 0.75 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.20 |
| SMA50 | $0.22 |
| SMA200 | $0.16 |
| RSI | nan |
| Shares Float | 4.29M |
| Volatility | 60168.52 |
| Rel Volume | 20.00 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +6.91% |
| 6 Months | +66.12% |
| YTD | +66.12% |
| Year | +5.79% |
| 3 Years | -9.05% |
| 5 Years | -46.04% |
| 10 Years | +34.00% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-19 | $0.20 | 10,000 |
| 2026-06-18 | $0.20 | 0 |
| 2026-06-17 | $0.20 | 0 |
| 2026-06-16 | $0.20 | 0 |
| 2026-06-15 | $0.20 | 0 |
| 2026-06-12 | $0.20 | 0 |
| 2026-06-11 | $0.20 | 0 |
| 2026-06-10 | $0.20 | 0 |
| 2026-06-09 | $0.20 | 0 |
| 2026-06-08 | $0.20 | 0 |
| 2026-06-05 | $0.20 | 0 |
| 2026-06-04 | $0.20 | 0 |
| 2026-06-03 | $0.20 | 0 |
| 2026-06-02 | $0.20 | 0 |
| 2026-06-01 | $0.20 | 0 |
| 2026-05-29 | $0.20 | 0 |
| 2026-05-28 | $0.20 | 0 |
| 2026-05-27 | $0.20 | 0 |
| 2026-05-26 | $0.20 | 0 |
| 2026-05-22 | $0.20 | 0 |
| 2026-05-21 | $0.20 | 0 |
| 2026-05-20 | $0.20 | 200 |
| 2026-05-19 | $0.20 | 0 |
About Procyon Corporation
Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matrix, collagen powder, foam, hydrogel, and rolled gauze wound care kits under the AMERX brand. The company also offers AMERIGEL hand sanitizer; EXTREMIT-EASE compression garment products; Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; calcium alginate, foam, and gauze dressings; retention tapes; and helix collagen gel. It sells its products to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners; and retail customers through distributors, and direct and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.
đ° Latest News
How Procyonâs Phil Fiore Built a $9.2 Billion âFamily Office for Middle Americaâ
Barrons.com âĸ 2026-05-01T15:58:00ZDeals & Moves: Lido Buys LA-Area RIA, Vestwell to Add 30K Gusto 401(k) Plans
Wealth Management âĸ 2025-12-12T18:16:21ZProcyon acquires OLV to expand presence in US
Private Banker International âĸ 2025-12-09T09:59:03ZDynasty-Backed Procyon Acquires $500M OLV Investment Group
Wealth Management âĸ 2025-12-08T19:02:02ZProcyon acquires Connecticut RIA Wooster Corthell
Private Banker International âĸ 2025-07-09T14:49:03ZIncome Statement (Annual)
| Metric | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,092,998 | $1,117,072 | $1,356,612 | $1,330,979 |
| Cost Of Revenue | $1,092,998 | $1,117,072 | $1,356,612 | $1,330,979 |
| Total Revenue | $4,984,433 | $4,686,659 | $4,842,433 | $4,719,672 |
| Operating Revenue | $4,984,433 | $4,686,659 | $4,842,433 | $4,719,672 |
| Expenses | ||||
| Interest Expense | $0 | $0 | $0 | $2,172 |
| Total Expenses | $5,216,138 | $4,784,040 | $5,079,648 | $4,492,998 |
| Other Income Expense | $35,782 | $20,191 | - | $508,059 |
| Other Non Operating Income Expenses | $36,022 | $20,191 | - | - |
| Net Non Operating Interest Income Expense | $24,641 | $11,816 | $1,804 | $-940 |
| Interest Expense Non Operating | $0 | $0 | $0 | $2,172 |
| Operating Expense | $4,123,140 | $3,666,968 | $3,723,036 | $3,162,019 |
| General And Administrative Expense | $4,123,140 | $3,666,968 | $3,723,036 | $3,162,019 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-341,140 | $-50,245 | $-209,790 | $694,349 |
| Net Interest Income | $24,641 | $11,816 | $1,804 | $-940 |
| Interest Income | $24,641 | $11,816 | $1,804 | $1,232 |
| Normalized Income | $-340,950 | $-50,245 | $-209,790 | $213,600 |
| Net Income From Continuing And Discontinued Operation | $-341,140 | $-50,245 | $-209,790 | $694,349 |
| Total Operating Income As Reported | $-231,705 | $-97,381 | $-237,215 | $226,674 |
| Net Income Common Stockholders | $-312,962 | $-66,955 | $-226,500 | $677,639 |
| Net Income | $-341,140 | $-50,245 | $-209,790 | $694,349 |
| Net Income Including Noncontrolling Interests | $-341,140 | $-50,245 | $-209,790 | $694,349 |
| Net Income Continuous Operations | $-341,140 | $-50,245 | $-209,790 | $694,349 |
| Pretax Income | $-171,282 | $-65,374 | $-235,411 | $733,793 |
| Special Income Charges | $-240 | $0 | $0 | $508,059 |
| Interest Income Non Operating | $24,641 | $11,816 | $1,804 | $1,232 |
| Operating Income | $-231,705 | $-97,381 | $-237,215 | $226,674 |
| Gross Profit | $3,891,435 | $3,569,587 | $3,485,821 | $3,388,693 |
| Per Share | ||||
| Diluted EPS | - | $-0.01 | $-0.03 | $0.08 |
| Basic EPS | - | $-0.01 | $-0.03 | $0.08 |
| Other | ||||
| Tax Effect Of Unusual Items | $-50 | $0 | $0 | $27,310 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $99,688 | $166,428 | $-22,809 | $392,218 |
| Total Unusual Items | $-240 | $0 | $0 | $508,059 |
| Total Unusual Items Excluding Goodwill | $-240 | $0 | $0 | $508,059 |
| Reconciled Depreciation | $270,730 | $231,802 | $214,406 | $164,312 |
| EBITDA (Bullshit earnings) | $99,448 | $166,428 | $-22,809 | $900,277 |
| EBIT | $-171,282 | $-65,374 | $-237,215 | $735,965 |
| Diluted NI Availto Com Stockholders | $-312,962 | $-66,955 | $-226,500 | $677,639 |
| Preferred Stock Dividends | $-28,178 | $16,710 | $16,710 | $16,710 |
| Tax Provision | $169,858 | $-15,129 | $-25,621 | $39,444 |
| Gain On Sale Of Ppe | $-1,214 | $0 | $0 | $304,887 |
| Other Special Charges | $-974 | - | - | $-203,172 |
| Selling General And Administration | $4,123,140 | $3,666,968 | $3,723,036 | $3,162,019 |
| Other Gand A | $2,037,931 | $1,806,988 | $1,710,606 | $1,330,215 |
| Salaries And Wages | $2,085,209 | $1,859,980 | $2,012,430 | $1,831,804 |
| Diluted Average Shares | - | $8,087,388 | $8,087,388 | $8,319,624 |
| Basic Average Shares | - | $8,087,388 | $8,087,388 | $8,087,388 |
Balance Sheet (Annual)
| Metric | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,270,290 | $2,600,709 | $2,650,954 | $2,860,744 |
| Total Assets | $3,204,412 | $3,563,711 | $3,802,497 | $4,267,191 |
| Total Non Current Assets | $838,527 | $1,326,106 | $1,217,443 | $1,395,564 |
| Other Non Current Assets | $216,701 | $330,513 | $182,224 | $263,280 |
| Non Current Prepaid Assets | $4,665 | $9,220 | $12,311 | $3,235 |
| Non Current Deferred Assets | $0 | $161,180 | $146,051 | $120,430 |
| Non Current Deferred Taxes Assets | $0 | $161,180 | $146,051 | $120,430 |
| Goodwill And Other Intangible Assets | $17,000 | $17,000 | $17,000 | $17,000 |
| Current Assets | $2,365,885 | $2,237,605 | $2,585,054 | $2,871,627 |
| Prepaid Assets | $434,150 | $298,469 | $374,817 | $276,251 |
| Inventory | $510,006 | $431,405 | $761,651 | $591,058 |
| Receivables | $512,909 | $493,953 | $407,085 | $497,358 |
| Accounts Receivable | $512,909 | $493,953 | $407,085 | $497,358 |
| Allowance For Doubtful Accounts Receivable | $-15,000 | $-11,625 | $-13,569 | $-9,408 |
| Gross Accounts Receivable | $527,909 | $505,578 | $420,654 | $506,766 |
| Cash Cash Equivalents And Short Term Investments | $908,820 | $1,013,778 | $1,041,501 | $1,506,960 |
| Cash And Cash Equivalents | $326,143 | $451,306 | $760,396 | $1,226,522 |
| Cash Financial | $326,143 | $451,306 | $760,396 | $1,226,522 |
| Debt | ||||
| Total Debt | $319,876 | $493,447 | $653,859 | $807,882 |
| Long Term Debt And Capital Lease Obligation | $139,211 | $319,882 | $491,312 | $653,860 |
| Current Debt And Capital Lease Obligation | $180,665 | $173,565 | $162,547 | $154,022 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $917,122 | $946,002 | $1,134,543 | $1,389,447 |
| Total Non Current Liabilities Net Minority Interest | $147,888 | $319,882 | $491,312 | $653,860 |
| Non Current Deferred Liabilities | $8,677 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $8,677 | $0 | - | - |
| Current Liabilities | $769,234 | $626,120 | $643,231 | $735,587 |
| Payables And Accrued Expenses | $588,569 | $452,555 | $480,684 | $581,565 |
| Payables | $160,922 | $175,057 | $178,083 | $167,588 |
| Accounts Payable | $160,922 | $175,057 | $178,083 | $167,588 |
| Equity | ||||
| Common Stock Equity | $2,172,630 | $2,490,849 | $2,541,094 | $2,750,884 |
| Preferred Stock Equity | $114,660 | $126,860 | $126,860 | $126,860 |
| Total Equity Gross Minority Interest | $2,287,290 | $2,617,709 | $2,667,954 | $2,877,744 |
| Stockholders Equity | $2,287,290 | $2,617,709 | $2,667,954 | $2,877,744 |
| Retained Earnings | $-2,330,621 | $-1,989,481 | $-1,939,236 | $-1,729,446 |
| Other | ||||
| Ordinary Shares Number | $8,120,388 | $8,087,388 | $8,087,388 | $8,087,388 |
| Share Issued | $8,120,388 | $8,087,388 | $8,087,388 | $8,087,388 |
| Tangible Book Value | $2,155,630 | $2,473,849 | $2,524,094 | $2,733,884 |
| Invested Capital | $2,172,630 | $2,490,849 | $2,541,094 | $2,750,884 |
| Working Capital | $1,596,651 | $1,611,485 | $1,941,823 | $2,136,040 |
| Capital Lease Obligations | $319,876 | $493,447 | $653,859 | $807,882 |
| Total Capitalization | $2,287,290 | $2,617,709 | $2,667,954 | $2,877,744 |
| Additional Paid In Capital | $41,085 | $35,564 | $35,564 | $35,564 |
| Capital Stock | $4,576,826 | $4,571,626 | $4,571,626 | $4,571,626 |
| Common Stock | $4,462,166 | $4,444,766 | $4,444,766 | $4,444,766 |
| Preferred Stock | $114,660 | $126,860 | $126,860 | $126,860 |
| Long Term Capital Lease Obligation | $139,211 | $319,882 | $491,312 | $653,860 |
| Current Capital Lease Obligation | $180,665 | $173,565 | $162,547 | $154,022 |
| Current Accrued Expenses | $427,647 | $277,498 | $302,601 | $413,977 |
| Net PPE | $600,161 | $808,193 | $859,857 | $991,619 |
| Accumulated Depreciation | $-938,286 | $-325,860 | $-273,043 | $-255,788 |
| Gross PPE | $1,538,447 | $1,134,053 | $1,132,900 | $1,247,407 |
| Leases | $27,142 | $42,289 | $35,907 | $26,301 |
| Other Properties | $1,001,655 | $553,922 | $732,907 | $908,593 |
| Machinery Furniture Equipment | $487,157 | $519,450 | $345,694 | $294,121 |
| Buildings And Improvements | $22,493 | $18,392 | $18,392 | $18,392 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $582,677 | $562,472 | $281,105 | $280,438 |
| Land And Improvements | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-125,163 | $-34,672 | $-466,126 | $214,334 |
| Operating Activities | ||||
| Operating Cash Flow | $-61,251 | $145,466 | $-383,482 | $279,500 |
| Cash Flow From Continuing Operating Activities | $-61,251 | $145,466 | $-383,482 | $279,500 |
| Operating Gains Losses | $1,214 | - | - | $-508,059 |
| Investing Activities | ||||
| Capital Expenditure | $-63,912 | $-180,138 | $-82,644 | $-65,166 |
| Investing Cash Flow | $-63,912 | $-454,556 | $-82,644 | $480,137 |
| Cash Flow From Continuing Investing Activities | $-63,912 | $-454,556 | $-82,644 | $480,137 |
| Net Other Investing Changes | - | $-274,418 | - | $-125,000 |
| Financing Activities | ||||
| Financing Cash Flow | $0 | $0 | $0 | $-198,949 |
| Cash Flow From Continuing Financing Activities | - | - | $-154,023 | $-198,949 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $326,143 | $451,306 | $760,396 | $1,226,522 |
| Beginning Cash Position | $451,306 | $760,396 | $1,226,522 | $665,834 |
| Changes In Cash | $-125,163 | $-309,090 | $-466,126 | $560,688 |
| Net PPE Purchase And Sale | $-63,912 | $-180,138 | $-82,644 | $605,137 |
| Sale Of PPE | $0 | $0 | $0 | $670,303 |
| Purchase Of PPE | $-63,912 | $-180,138 | $-82,644 | $-65,166 |
| Change In Working Capital | $28,489 | $148,343 | $-211,948 | $-129,919 |
| Change In Payables And Accrued Expense | $146,735 | $-28,129 | $-100,881 | $160,562 |
| Change In Accrued Expense | $160,870 | $-25,103 | $-111,376 | $160,433 |
| Change In Payable | $-14,135 | $-3,026 | $10,495 | $129 |
| Change In Account Payable | $-14,135 | $-3,026 | $10,495 | $129 |
| Change In Prepaid Assets | $-131,126 | $79,439 | $-107,642 | $-92,156 |
| Change In Inventory | $35,211 | $181,957 | $-89,537 | $-12,010 |
| Change In Receivables | $-22,331 | $-84,924 | $86,112 | $-186,315 |
| Changes In Account Receivables | $-22,331 | $-84,924 | $86,112 | $-186,315 |
| Other Non Cash Items | $-193,776 | $-167,361 | $-154,690 | $-306 |
| Provisionand Write Offof Assets | $212,378 | $-33,904 | $36,121 | $-144,619 |
| Deferred Tax | $-39,146 | $16,831 | $-57,581 | $184,063 |
| Deferred Income Tax | $-39,146 | $16,831 | $-57,581 | $184,063 |
| Depreciation Amortization Depletion | $270,730 | $231,802 | $214,406 | $164,312 |
| Depreciation And Amortization | $270,730 | $231,802 | $214,406 | $164,312 |
| Depreciation | $270,730 | $231,802 | $214,406 | $164,312 |
| Net Income From Continuing Operations | $-341,140 | $-50,245 | $-209,790 | $694,349 |
| Stock Based Compensation | - | $0 | $0 | $19,679 |
| Repayment Of Debt | - | - | $-154,023 | $-198,949 |
| Issuance Of Debt | - | - | $0 | $0 |
| Net Issuance Payments Of Debt | - | - | $-154,023 | $-198,949 |
| Net Long Term Debt Issuance | - | - | $-154,023 | $-198,949 |
| Long Term Debt Payments | - | - | $-154,023 | $-198,949 |
| Long Term Debt Issuance | - | - | $0 | $0 |
| Net Investment Purchase And Sale | - | - | - | $-125,000 |
| Purchase Of Investment | - | - | - | $-125,000 |
| Change In Interest Payable | - | - | - | $2,172 |